About EpiCapture
EpiCapture is a Healthcare company based in Dublin (Ireland) founded in 2021, and was acquired by Trinity Biotech in October 2024. Non-invasive liquid tests for cancer detection are developed. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified.
Company details
EpiCapture was founded in 2021 in Dublin, Ireland, within the biotechnology sector. Non-invasive liquid biopsy tests for early cancer detection are developed by the company. These tests utilize epigenetic markers to identify cancer signals in bodily fluids, avoiding traditional invasive methods. Operations are based in Ireland, with a focus on advancing diagnostic tools for oncology applications. The domain epicapturedx.com supports ongoing research and development activities.
- Headquarters Dublin, Ireland
- Stage Acquired
- SectorsHealthcare
- Website epicapturedx.com
- Acquired by Trinity Biotech (Oct 2024)
- Investors
- Acquired byTrinity Biotech
(Oct 2024)
Investors in EpiCapture
EpiCapture has secured backing from 1 investor. Prominent investors backing the company include Trinity Biotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of In vitro diagnostic kits for clinical labs | 1992 | trinitybiotech.com | Bray, Ireland |
Investor details for EpiCapture
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of EpiCapture
2 dated milestones of EpiCapture across 3 years, from founding to its latest funding, stage changes and deals.
- Founded EpiCapture is founded.
- Exit Acquired by Trinity Biotech.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Epicapture
Complete news archive for EpiCapture
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EpiCapture
EpiCapture was founded in 2021.
EpiCapture is headquartered in Dublin, Ireland.
EpiCapture was founded in 2021 in Dublin, Ireland, within the biotechnology sector. Non-invasive liquid biopsy tests for early cancer detection are developed by the company. These tests utilize epigenetic markers to identify cancer signals in bodily fluids, avoiding traditional invasive methods. Operations are based in Ireland, with a focus on advancing diagnostic tools for oncology applications. The domain epicapturedx.com supports ongoing research and development activities.
EpiCapture has 1 investor. Key investors include Trinity Biotech.
Yes. EpiCapture was acquired by Trinity Biotech in October 2024.